Navigation Links
Wellspring Hires Sanford Devries as Controller
Date:7/27/2009

/p>

Wellspring is one of the fastest growing companies in California in the field of Applied Behavior Analysis with multiple offices in Southern California. Wellspring employs ethical and experienced professionals who are passionate about meeting the behavioral needs of their clients and improving their quality of life. Wellspring is committed to being at the forefront of the behavioral health services industry and a leader of autism treatment. The company is on the cutting edge of the latest research, updated educational plans, business trends and technology to ensure the success of its employees and its clients.


'/>"/>
SOURCE Wellspring
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Wellspring Coordinates With CA Health Insurance Plans to Pay for Autism Treatments
2. Wellspring Hires William Young and Prepares for Nationwide Expansion
3. WellSpring Pharmaceutical Corp. Emetrol(R) Consumer Brand Achieves Number One Position in Anti-Nausea Category
4. WellSpring Pharmaceutical Corp. Names Wendy Shusko as New Chief Operating Officer
5. WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business
6. National Coalition of Mental Health Consumer/Survivor Organizations Hires Director of Government Relations
7. Cord Blood America Hires Management Team for Its New Stem Cell Laboratory
8. MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP, Group Account Director
9. Pennsylvania Patient Safety Authority Hires Patient Safety Liaison (PSL) to Help Healthcare Facilities Implement Guidance
10. XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development
11. Astellas Hires New Vice President of Compliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RNewswire/--NIP,Inc.todayannouncedtheacquisitionof...ingexecutivecompensationandbenefitplanprovidershea...esinLosAngeles,Milwaukee,Boston,ChicagoandAtlanta....ertintheexecutivebenefitsindustry. ,, "Weareexc...gnificantmarketpresence,"statesBillPollock,Chairma...
(Date:11/24/2009)...Nov.24/PRNewswire/--Nextmonth,UnitedHealthcarewill...gHispanic-AmericanseniorsunderstandthebasicsofMedi...eafreeZumba®Goldclass,aLatin-infusedfitnesspr...umba,andtango. ,, UnitedHealthcarewillofferthes...engagedwhenlearningabouttheirhealthcareoptions. T...
(Date:11/24/2009)...ewswire/--TheUnionLaborLifeInsuranceCompany("Union...#174;),()thenation,slargestvisionbenefitsandservic...tounions,uniontrustfunds,unionemployersandtheirmem...servicesincludingcomprehensiveeyeexams,broadselect...ntqualityeyecareis,"statedBruceSmith,NationalSales...
(Date:11/24/2009)... help ward off peripheral artery disease, researc... News) -- Among people aged 75 and older, the herb... attacks, stroke or death, a new study finds. ,...medy might help prevent the leg-circulation proble..., Ginkgo contains nutrients called flavonoids, whi...
(Date:11/24/2009)...t differ greatly between high- and low-volume cent...ealthDay News) -- Do hospitals that conduct the mo...lts for patients? Maybe not. , Prior research h... comes to artery-opening procedures, but a new stu...igh-volume hospitals performing more or less equal...
Breaking Medicine News(10 mins):Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3
...tuberculosis drug, currently in the experimental p... drug resistant and latent infections as well. The...// than those used for conventional treatment. ...d spectrum of non-pathogenic microorganisms that e...
...s to be profound links between land-based pollutio...o scientists, physicians, and veterinarians, that .../ According to Paul Sandifer, Chief Scientist ...ues of our unseen impact on the sea, there is moun...
...s come into existence to protect the traditional k...es. Charles McManis, J.D., IP and technology law ...at Washington University in St. Louis has come wit...hey said that existing intellectual property regim...
...Cunnane, a metabolic physiologist at the Universit...d secure shore-based diet that fuelled and provide...they are today. Early hominid brains // underwent ...owth. Our brains weigh roughly twice as much as th...
...titioned for reduction on VAT for condoms, to be r...arrant abolishment of VAT on condoms, the best tha...gly invoked a re-categorization of condoms from a ...m Fins bury, a High Street retailer, who wishes an...
...ty of Jerusalem researchers report that another he...duce cholesterol in blood. As a result it reduces ... has found that heart patients who eat one grapefr... in the reduction of incidence of heart ailments a...
Other Medicine News:Health News:New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment 2Health News:Mystery behind the evolution of the Human brain 2Health News:One fruit that has captured the health benefit sector is Grapefruit! 2
(Date:11/24/2009)...OXThanksgivingDaytelevisionspecialcalled"Kaleidosc...ttheholidaysareatimetobegratefulformanydevelopment...tbattleeachdayassurvivors,caregivers,andadvocates....eiceofcancersurvivorsScottHamiltonandDorothyHamill...rwhowillperform"HopeisAlwaysHere,"asongwrittenbych...
(Date:11/24/2009)...e-FirstCall/--BioSpecificsTechnologiesCorp.(Nasdaq...nclasscollagenase-basedproducts,todayannouncedthat...pcomingPiperJaffray21stAnnualHealthCareConferenceo...ceHotelinNewYork,NY. ,, Alivewebcastofthepresen...estorRelationssectionoftheCompany,swebsiteat www.b...
(Date:11/23/2009)...ooftheChicagoarea,sleadingBoardCertifiedDiagnostic...aging,couplingthelatesttechnologyindigitalmammogra...tytohavethefullrangeofdigitalimagingcompleted,diag...ffice.Drs.AhmedFaragandJoanWerberaredeliveringthis...waitforanappointmentcommonlyfoundinChicago,fromthe...
Breaking Medicine Technology:FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 1Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 2Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 3New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 1New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 2New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 3Resurrection Medical Center Among Top 5 25 of Hospitals Nationwide for Womens Health 51646 1Resurrection Medical Center Among Top 5 25 of Hospitals Nationwide for Womens Health 51646 2
...ual Meeting of EASL , , Management to Discuss Stu...Results Call at 5 P.M. EDT Today , , SAN DIEGO, ...ANDS ) today announced that ANA598, the Company,s ...r, demonstrated potent antiviral activity at all d...udy in which patients chronically infected with th...
...d nearly double SVR rate compared to standard of c...hibitor SCH 900518 presented at EASL annual meetin...ugh Corporation (NYSE: SGP ) today reported that...ceprevir, its investigational oral hepatitis C pro... alfa-2b and ribavirin, significantly increased su...
Other Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: